Registration is now open for the Fifth Global Cardio-Oncology Summit on October 3–4, 2019, in São Paulo, Brazil. The event is co-hosted by the International CardiOncology Society, the Canadian Cardiac Oncology Network, the British Cardio-Oncology Society, and the Brazilian Cardiology Society (SBC) and Brazilian Society of Clinical Oncology (SBOC). Click here for more information.
Global Cardio-Oncology Summit
Aims and scope
The editorial mission of Cardio-Oncology is to advance the science and practice of this emerging field to find a balance between oncologic efficacy and reducing adverse cardiovascular effects through timely publication and dissemination of peer-reviewed research. As an open access, online journal Cardio-Oncology provides a high visibility platform for the publication of original research and expert reviews on the cardiovascular effects of cancer treatment.
Read more here.
About the society
Cardio-Oncology is the official journal of the International Cardio-Oncology Society (ICOS). The society brings together cardio-oncologists from around the world with the aim of reducing cardiovascular disease in cancer patients and thereby saving patients' lives. For more information about this important work, please visit the ICOS website.
To learn more about the affiliation between Cardio-Oncology and ICOS, please see this blog on the BMC blog network.
About the Editors
Steven Lipshultz, Editor-in-Chief
Steven E. Lipshultz, MD, FAAP, FAHA is the A. Conger Goodyear Professor and Chair of the Department of Pediatrics at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, The State University of New York; the Chief of Service of Pediatrics at Kaleida Health; the Medical Director of Pediatric Services Business Development at John R. Oishei Children’s Hospital; President of UBMD Pediatrics (University at Buffalo Pediatric Associates, Inc.); and a Consultant in Pediatrics and Cardio-Oncology for the Roswell Park Comprehensive Cancer Center.
Joseph Carver, Deputy Editor
Joseph Carver is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, the Chief Operating Officer of the Abramson Family Cancer Research Institute of the Abramson Cancer Center of the University of Pennsylvania and the Chief of Staff of the Abramson Cancer Center.
Giorgio Minotti, Deputy Editor
Giorgio Minotti is Professor of Pharmacology, Head of Drug Sciences and Clinical Pharmacology, Chief of Clinical Trial Center, at the University Campus Bio-Medico of Rome. His research interests focus on pharmacokinetics, pharmacodynamics, and clinical correlates of anticancer drugs cardiovascular toxicity.
Cardio-Oncology is affiliated with the International Cardio-Oncology Society (ICOS).
- Editorial Board
- Sign up for article alerts and news from this journal
Annual Journal Metrics
31 days to first decision for reviewed manuscripts only
29 days to first decision for all manuscripts
73 days from submission to acceptance
15 days from acceptance to publication
44 Altmetric Mentions
On the blog
09 September 2019
06 September 2019
Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).